{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:22:33Z","timestamp":1791818553418,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.phrs.2021.105431","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T11:18:48Z","timestamp":1612005528000},"page":"105431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Combined inhibition of histone deacetylases and BET family proteins as epigenetic therapy for nerve injury-induced neuropathic pain"],"prefix":"10.1016","volume":"165","author":[{"given":"Vittoria","family":"Borgonetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1812-9844","authenticated-orcid":false,"given":"Nicoletta","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105431_bib0005","article-title":"Neuropathic pain: from mechanisms to treatment","author":"Finnerup","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2021.105431_bib0010","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2021.105431_bib0020","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.phrs.2021.105431_bib0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2021.105431_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tins.2015.02.001","article-title":"Epigenetic mechanisms of chronic pain","volume":"38","author":"Descalzi","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2021.105431_bib0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/jpet.115.231670","article-title":"Targeting epigenetic mechanisms for chronic pain: a valid approach for the development of novel therapeutics","volume":"357","author":"Ligon","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2021.105431_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/ACO.0000000000000613","article-title":"Epigenetics of pain mediators","volume":"31","author":"Odell","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.phrs.2021.105431_bib0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018762","article-title":"Writers and readers of histone acetylation: structure, mechanism, and inhibition","volume":"6","author":"Marmorstein","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.phrs.2021.105431_bib0050","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105431_bib0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cncr.25584","article-title":"Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma","volume":"117","author":"Niesvizky","year":"2011","journal-title":"Cancer."},{"key":"10.1016\/j.phrs.2021.105431_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2119\/molmed.2011.00030","article-title":"HDAC Inhibition in rheumatoid arthritis and juvenile idiopathic arthritis","volume":"17","author":"Vojinovic","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2021.105431_bib0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01740-5","article-title":"Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia","volume":"17","author":"He","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2021.105431_bib0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/WNR.0000000000000558","article-title":"Suberoylanilide hydroxamic acid prevents downregulation of spinal glutamate transporter-1 and attenuates spinal nerve ligation-induced neuropathic pain behavior","volume":"27","author":"Cui","year":"2016","journal-title":"NeuroReport"},{"key":"10.1016\/j.phrs.2021.105431_bib0075","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918796763","article-title":"Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model","volume":"14","author":"Danaher","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0080","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.pain.2013.05.021","article-title":"HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain","volume":"154","author":"Denk","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pbb.2017.08.006","article-title":"The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse model","volume":"160","author":"Sanna","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105431_bib0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/WNR.0000000000000992","article-title":"Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats","volume":"29","author":"Takahashi","year":"2018","journal-title":"NeuroReport"},{"key":"10.1016\/j.phrs.2021.105431_bib0095","article-title":"From combinations to multitarget-directed ligands: a continuum in Alzheimer\u2019s disease polypharmacology","author":"Albertini","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2021.105431_bib0100","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2021.105431_bib0105","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/j.pain.0000000000000164","article-title":"Activation of JNK pathway in spinal astrocytes contributes to acute ultra-low-dose morphine thermal hyperalgesia","volume":"156","author":"Sanna","year":"2015","journal-title":"Pain."},{"key":"10.1016\/j.phrs.2021.105431_bib0110","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105431_bib0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mp.2011.92","article-title":"Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects","volume":"17","author":"Bortolozzi","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105431_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2005.10.036","article-title":"Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse","volume":"122","author":"Bourquin","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fphar.2019.00472","article-title":"Lavender (Lavandula angustifolia mill.) essential oil alleviates neuropathic pain in mice with spared nerve injury","volume":"10","author":"Sanna","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12035-019-01706-6","article-title":"\u039c opioid receptor-triggered Notch-1 activation contributes to morphine tolerance: role of neuron\u2013glia communication","volume":"57","author":"Sanna","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105431_bib0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuropharm.2017.10.025","article-title":"Activation of ERK\/CREB pathway in noradrenergic neurons contributes to hypernociceptive phenotype in H4 receptor knockout mice after nerve injury","volume":"128","author":"Sanna","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105431_bib0150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14789450.2017.1388167","article-title":"Protein purification and analysis: next generation western blotting techniques","volume":"14","author":"Mishra","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.phrs.2021.105431_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bph.13644","article-title":"Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress","volume":"174","author":"Sanna","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13621","article-title":"Complex regulation of the regulator of synaptic plasticity histone deacetylase 2 in the rodent dorsal horn after peripheral injury","volume":"138","author":"Maiar\u00f9","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2021.105431_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2018.02.034","article-title":"The HDAC1\/c-JUN complex is essential in the promotion of nerve injury-induced neuropathic pain through JNK signaling","volume":"825","author":"Sanna","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijdevneu.2013.02.005","article-title":"Unique functional roles for class I and class II histone deacetylases in central nervous system development and function","volume":"31","author":"Morris","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105431_bib0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/bph.13657","article-title":"The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-\u03baB and MAPK activation","volume":"174","author":"Huang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0180","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918798408","article-title":"The etiological changes of acetylation in peripheral nerve injury\u2013induced neuropathic hypersensitivity","volume":"14","author":"Wang","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0185","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2021.105431_bib0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105431_bib0195","doi-asserted-by":"crossref","first-page":"E2721","DOI":"10.1073\/pnas.1406722111","article-title":"BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma","volume":"111","author":"Bhadury","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2021.105431_bib0200","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1535-7163.MCT-13-0770","article-title":"Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells","volume":"13","author":"Fiskus","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2021.105431_bib0205","doi-asserted-by":"crossref","first-page":"21507","DOI":"10.18632\/oncotarget.4242","article-title":"Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling","volume":"6","author":"Heinemann","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2021.105431_bib0210","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neo.2018.11.006","article-title":"Preclinical studies support combined inhibition of BET family proteins and histone deacetylases as epigenetic therapy for cutaneous T-Cell lymphoma","volume":"21","author":"Zhao","year":"2019","journal-title":"Neoplasia (United States)"},{"key":"10.1016\/j.phrs.2021.105431_bib0215","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kr\u00e4mer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2021.105431_bib0220","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jcp.24871","article-title":"HDAC4 degradation mediates HDAC inhibition-induced protective effects against Hypoxia\/Reoxygenation injury","volume":"230","author":"Du","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2021.105431_bib0225","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fnins.2019.00346","article-title":"Normalizing HDAC2 levels in the spinal cord alleviates thermal and mechanical hyperalgesia after peripheral nerve injury and promotes GAD65 and KCC2 expression","volume":"13","author":"Ouyang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2021.105431_bib0230","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/cells9061500","article-title":"Bromodomain protein BRD4 accelerates glucocorticoid dysregulation of bone mass and marrow adiposis by modulating H3K9 and Foxp1","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2021.105431_bib0235","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/j.pain.0000000000000739","article-title":"SIRT1 attenuates neuropathic pain by epigenetic regulation of mGluR1\/5 expressions in type 2 diabetic rats","volume":"158","author":"Zhou","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0240","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/ijms21030881","article-title":"High-mobility group box 1 protein signaling in painful diabetic neuropathy","volume":"21","author":"Thakur","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105431_bib0245","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jpain.2016.01.471","article-title":"Histone acetylation in microglia contributes to exercise-induced hypoalgesia in neuropathic pain model mice","volume":"17","author":"Kami","year":"2016","journal-title":"J. Pain"},{"key":"10.1016\/j.phrs.2021.105431_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nbd.2009.07.019","article-title":"Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo","volume":"36","author":"Faraco","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2021.105431_bib0255","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/163140","article-title":"Histone deacetylase inhibitor trichostatin a ameliorated endotoxin-induced neuroinflammation and cognitive dysfunction","volume":"2015","author":"Hsing","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.phrs.2021.105431_bib0260","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jnr.23221","article-title":"Histone deacetylase inhibitors suppress immune activation in primary mouse microglia","volume":"91","author":"Kannan","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2021.105431_bib0265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.expneurol.2018.08.005","article-title":"Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury","volume":"309","author":"Rudman","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2021.105431_bib0270","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2018.02.096","article-title":"Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia","volume":"497","author":"DeMars","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2021.105431_bib0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105431_bib0280","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105431_bib0285","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.14221","article-title":"BET Proteins: An Approach to Future Therapies in Transplantation","volume":"17","author":"Suarez-Alvarez","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.phrs.2021.105431_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.12.005","article-title":"Bromodomains: Structure, function and pharmacology of inhibition","volume":"106","author":"Ferri","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0295","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105431_bib0300","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2014-205809","article-title":"The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts","volume":"75","author":"Klein","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2021.105431_bib0305","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bbadis.2014.05.013","article-title":"I-BET151 selectively regulates IL-6 production","volume":"1842","author":"Barrett","year":"2014","journal-title":"Biochimica et Biophysica Acta \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2021.105431_bib0310","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/mol.117.110379","article-title":"RVX-297, a bet bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease","volume":"92","author":"Jahagirdar","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105431_bib0315","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2021.105431_bib0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-010-0825-z","article-title":"Identification of genes associated with chemosensitivity to SAHA\/taxane combination treatment in taxane-resistant breast cancer cells","volume":"125","author":"Chang","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2021.105431_bib0325","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biochi.2011.06.031","article-title":"SAHA\/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells","volume":"94","author":"Lauricella","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2021.105431_bib0330","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/cas.14102","article-title":"BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo","volume":"110","author":"Liu","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2021.105431_bib0335","doi-asserted-by":"crossref","first-page":"10015","DOI":"10.1021\/acsnano.9b01892","article-title":"Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury","volume":"13","author":"Guo","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2021.105431_bib0340","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:20:49Z","timestamp":1760912449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":68,"alternative-id":["S1043661821000141"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105431","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined inhibition of histone deacetylases and BET family proteins as epigenetic therapy for nerve injury-induced neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105431"}}